Hypoxic Clamp, Perfusate and Biocompatible Nanofabrication by Repurposing Semiconductor Fabrication Materials and Technologies

Abstract Retinopathy of Prematurity (ROP) is a leading cause of childhood blindness, driven by the disruption of normal retinal vascular development due to premature birth and subsequent oxygen therapy. Current treatments have limitations, highlighting the need for precise, localized control of oxygen levels in the developing retina. This paper introduces the "hypoxic clamp," a conceptual nano/microscale device designed to regulate oxygen tension in the retinal vasculature with high precision. The core innovation lies in repurposing semiconductor fabrication techniques and materials, leveraging their inherent advantages of miniaturization, scalability, and precision. Key enabling technologies include microfluidics, biocompatible polymers and metals, nanoscale oxygen sensors, and targeted delivery mechanisms. Beyond ROP, the hypoxic clamp concept has broad applicability in organ preservation, targeted drug delivery, advanced diagnostics, and regenerative medicine. This paper presents a positive outlook on the feasibility of this technology, outlining a phased development approach and highlighting the transformative potential of biocompatible nanofabrication. The long-term implications of precise physiological control at the microscale are explored, including the speculative, yet inspiring, possibility of ex vivo brain maintenance.